109 related articles for article (PubMed ID: 28002035)
21. Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis.
Tayyebi-Khosroshahi H; Houshyar J; Tabrizi A; Vatankhah AM; Razzagi Zonouz N; Dehghan-Hesari R
Iran J Kidney Dis; 2010 Oct; 4(4):322-6. PubMed ID: 20852375
[TBL] [Abstract][Full Text] [Related]
22. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
23. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Noorbala AA; Hashemi-Nazari SS; Mansournia MA
Eur J Clin Pharmacol; 2014 Jun; 70(6):655-65. PubMed ID: 24643636
[TBL] [Abstract][Full Text] [Related]
24. The effect of low dose omega-3 on plasma lipids in hemodialysis patients.
Taziki O; Lessan-Pezeshki M; Akha O; Vasheghani F
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945
[TBL] [Abstract][Full Text] [Related]
25. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients.
Abdollahzad H; Eghtesadi S; Nourmohammadi I; Khadem-Ansari M; Nejad-Gashti H; Esmaillzadeh A
Int J Vitam Nutr Res; 2009 Sep; 79(5-6):281-7. PubMed ID: 20533214
[TBL] [Abstract][Full Text] [Related]
26. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial.
Biniaz V; Tayebi A; Ebadi A; Sadeghi Shermeh M; Einollahi B
Iran J Kidney Dis; 2014 Sep; 8(5):401-7. PubMed ID: 25194408
[TBL] [Abstract][Full Text] [Related]
27. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
[TBL] [Abstract][Full Text] [Related]
28. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
Jakić M; Lovcić V; Klarić D; Mihaljević D; Zibar L; Jakić M; Marić I
Coll Antropol; 2010 Mar; 34 Suppl 1():181-8. PubMed ID: 20402316
[TBL] [Abstract][Full Text] [Related]
29. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
[TBL] [Abstract][Full Text] [Related]
30. Effects of simvastain combined with omega-3 fatty acids on high sensitive C-reactive protein, lipidemia, and fibrinolysis in patients with mixed dyslipidemia.
Hong H; Xu ZM; Pang BS; Cui L; Wei Y; Guo WJ; Mao YL; Yang XC
Chin Med Sci J; 2004 Jun; 19(2):145-9. PubMed ID: 15250255
[TBL] [Abstract][Full Text] [Related]
31. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.
Khatami MR; Mirchi E; Khazaeipour Z; Abdollahi A; Jahanmardi A
Iran J Kidney Dis; 2013 Jan; 7(1):47-52. PubMed ID: 23314142
[TBL] [Abstract][Full Text] [Related]
32. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
33. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
34. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA
J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
Poulia KA; Panagiotakos DB; Tourlede E; Rezou A; Stamatiadis D; Boletis J; Zampelas A
J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
[TBL] [Abstract][Full Text] [Related]
36. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
[TBL] [Abstract][Full Text] [Related]
37. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
[TBL] [Abstract][Full Text] [Related]
38. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
39. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
40. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
